CareDx To Participate in Upcoming Conferences

Rhea-AI Summary

CareDx, a precision medicine company focused on transplant patients, announced its participation in the 12th Annual Jefferies London Healthcare Conference and the 4th Annual Evercore ISI HealthCONx Conference. The management team will present at these events, with a pre-recorded fireside chat available starting November 18, 2021, at 8:00 AM GMT, and a live chat on December 1, 2021, at 2:15 PM EST. Interested investors can listen to the webcasts via the company’s investor relations website.

SOUTH SAN FRANCISCO, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced today the Company will participate in the 12^th Annual Jefferies London Healthcare Conference and the 4th Annual Evercore ISI HealthCONx Conference.

CareDx’ management team is scheduled to present at the following;

• The 12^th Annual Jefferies London Healthcare Conference and the pre-recorded fireside chat will be available beginning Thursday, November 18, 2021 at 8:00 AM GMT
  
• The 4th Annual Evercore ISI HealthCONx Conference with a fireside chat on Wednesday, December 1, 2021 at 2:15 PM EST
  

To listen to the webcasts, please visit the investor relations section of CareDx’s website at: investors.caredxinc.com.

Forward Looking Statements
This press release includes forward-looking statements related to CareDx, Inc., including statements regarding TxAccess and the integration of University of Alabama at Birmingham Comprehensive Transplant Institute with TxAccess (the “Integration”), and the potential benefits and results that may be achieved through TxAccess and the Integration. These forward-looking statements are based upon information that is currently available to CareDx and its current expectations, speak only as of the date hereof, and are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including risks that the CareDx does not realize the expected benefits of TxAccess and the Integration; general economic and market factors; and other risks discussed in CareDx’s filings with the SEC, including the Annual Report on Form 10-K for the fiscal year ended December 31, 2020 filed by CareDx with the SEC on February 24, 2021 and other reports that CareDx has filed with the SEC. Any of these may cause CareDx’s actual results, performance or achievements to differ materially and adversely from those anticipated or implied by CareDx’s forward-looking statements. CareDx expressly disclaims any obligation, except as required by law, or undertaking to update or revise any such forward-looking statements.

Contacts
Sasha King
Chief Marketing Officer
(415) 287-2393
sking@CareDx.com

Investor Relations
Ian Cooney
(415) 722-4563
investor@CareDx.com

FAQ

When will CareDx present at the Jefferies London Healthcare Conference?

CareDx will present at the Jefferies London Healthcare Conference on November 18, 2021, with a pre-recorded fireside chat available from 8:00 AM GMT.

What is the date and time for CareDx's presentation at the Evercore ISI HealthCONx Conference?

CareDx's presentation at the Evercore ISI HealthCONx Conference is scheduled for December 1, 2021, at 2:15 PM EST.

How can I listen to CareDx's conference presentations?

You can listen to CareDx's conference presentations by visiting the investor relations section of their website.

What is the stock symbol for CareDx?

The stock symbol for CareDx is CDNA.